FDA-cleared profile

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd. · PET/SPECT/Nuclear Medicine · FDA-cleared (510(k))

Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Clinical role
Supports patient and examination management, PET and CT acquisition, reconstruction, display and post-processing, quantitative PET review, PET/CT registration and fusion, networking, and filming. K232712 adds deep learning to uExcel Focus or OncoFocus respiratory-motion correction and adds uKinetics for direct and indirect PET parametric imaging.
Images and patients
PET/SPECT/Nuclear Medicine · Multi-region
Key limitation
Keep in mind: The system is intended to be operated by qualified healthcare professionals. Low dose CT lung cancer screening must be performed within the established inclusion criteria of programs/protocols approved and published by either a governmental body or professional medical society.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.
  • Which images or clinical context are in scope?Modality: PET/SPECT/Nuclear Medicine Anatomy or clinical context: Multi-region Input: Quantitative distribution information of PET radiopharmaceuticals within the patient body and CT diagnostic tomographic anatomical and photon attenuation information for the scanned region.
  • Who uses it?Intended users: Qualified healthcare professionals.
  • What does the software produce?Output: High quality functional and anatomical images, with accurate registration and fusion of PET and CT images; uKinetics generates direct and indirect parametric images.
  • What is its most important limitation?Key limitation: The system is intended to be operated by qualified healthcare professionals. Low dose CT lung cancer screening must be performed within the established inclusion criteria of programs/protocols approved and published by either a governmental body or professional medical society.

Clinical takeaway. Clinical role: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Evidence takeaway. Evidence from the reviewed source record: FDA-reviewed support includes manufacturer bench comparisons for the updated motion-correction and parametric-imaging functions plus a blind image comparison by two nuclear medicine physicians. The 510(k) summary does not report the clinical sample size, sites, or patient-outcomes endpoints.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.
  • Exact FDA submission
  • Checked 2026-09-19

Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.

Workflow role
Supports patient and examination management, PET and CT acquisition, reconstruction, display and post-processing, quantitative PET review, PET/CT registration and fusion, networking, and filming. K232712 adds deep learning to uExcel Focus or OncoFocus respiratory-motion correction and adds uKinetics for direct and indirect PET parametric imaging.
  • Exact FDA submission
  • Checked 2026-09-02
Required input
Quantitative distribution information of PET radiopharmaceuticals within the patient body and CT diagnostic tomographic anatomical and photon attenuation information for the scanned region.
  • Exact FDA submission
  • Checked 2026-09-19

The exact indications for use directly describe the PET radiopharmaceutical information and CT information provided by the two modalities.

Output and clinician action
High quality functional and anatomical images, with accurate registration and fusion of PET and CT images; uKinetics generates direct and indirect parametric images.
  • Exact FDA submission
  • Checked 2026-09-19

The exact device description and indications for use support the image, registration/fusion, and uKinetics output wording without adding the dossier's unsupported review claim.

Care setting
Professional healthcare facilities performing diagnostic PET/CT and CT imaging.
  • Exact FDA submission
  • Checked 2026-09-02
Intended users
Qualified healthcare professionals.
  • Exact FDA submission
  • Checked 2026-09-19

The exact indications for use state that the system is intended to be operated by qualified healthcare professionals.

Limitations
The system is intended to be operated by qualified healthcare professionals. Low dose CT lung cancer screening must be performed within the established inclusion criteria of programs/protocols approved and published by either a governmental body or professional medical society.
  • Exact FDA submission
  • Checked 2026-09-19

The exact indications for use state the qualified-user boundary and the required approval/publication boundary for low-dose CT lung cancer screening.

Evidence summary
FDA-reviewed support includes manufacturer bench comparisons for the updated motion-correction and parametric-imaging functions plus a blind image comparison by two nuclear medicine physicians. The 510(k) summary does not report the clinical sample size, sites, or patient-outcomes endpoints.
  • Exact FDA submission
  • Checked 2026-09-02

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA-reviewed support includes manufacturer bench comparisons for the updated motion-correction and parametric-imaging functions plus a blind image comparison by two nuclear medicine physicians. The 510(k) summary does not report the clinical sample size, sites, or patient-outcomes endpoints.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-02
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K232712 uExcel Focus and uKinetics bench testing

  • DesignManufacturer bench comparison of motion-corrected and uncorrected PET measurements plus parametric-image accuracy testing
  • PopulationBench PET datasets and hot-sphere or background measurements; sample counts were not reported in the 510(k) summary
  • Scopeexact submission
  • Tested versionK232712 uExcel Focus or OncoFocus deep-learning update and uKinetics
  • IndependenceSponsor or vendor study

K232712

Endpoints included lesion volume, SUVmax, SUVmean, input-function area-under-the-curve bias, Ki and intercept bias, and background coefficient of variation; numeric results were not reported in the summary.

K232712 blind uExcel Focus clinical image comparison

  • DesignManufacturer-sponsored blind image comparison by two U.S. board-certified nuclear medicine physicians
  • PopulationClinical PET/CT images processed with uExcel Focus; examination count and sites were not reported in the 510(k) summary
  • Scopeexact submission
  • Tested versionK232712 uExcel Focus or OncoFocus deep-learning update
  • IndependenceSponsor or vendor study

K232712

Both readers considered all reviewed images sufficient for diagnosis and observed reduced attenuation-correction artifacts and improved PET/CT alignment. The summary does not report reader-agreement or patient-outcome endpoints.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
FDA recall Z-0225-2026 affects uMI Panorama 35 systems. A third-party outer cover could become trapped between the patient table and gantry and interfere with table movement. FDA lists the recall as open and classified.
  • FDA source
  • Exact product version
  • Checked 2026-09-04

Each published event was manually matched to the exact FDA submission and affected product or version; a recall does not establish an AI-algorithm defect or current site exposure unless the event states that scope.

recall: Z-0225-2026

Open, Classified

2025-10-21

Exact uMI Panorama 35 model and native submission match. The recall is limited to affected model 35 units and describes a mechanical or accessory-use issue, not an AI-algorithm defect.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Quantitative distribution information of PET radiopharmaceuticals within the patient body and CT diagnostic tomographic anatomical and photon attenuation information for the scanned region.

    Scope: Exact FDA submission. The exact indications for use directly describe the PET radiopharmaceutical information and CT information provided by the two modalities.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K232712: uMI Panorama

  2. Routing

    Source context, not route validation: The scanner control and reconstruction environment provides data and patient management, networking, display and post-processing, and DICOM-standard image exchange.

    Scope: Exact FDA submission. Confirm supported DICOM services, object types, PACS and RIS connectivity, worklist behavior, quantitative-image handling, and interface versions for the installed configuration.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-02 · FDA K232712: uMI Panorama

  3. AI processing

    Source context, not route validation: On-premises uMI Panorama 28 or 35 PET/CT scanner with a 760 mm bore, integrated patient table, and system control and reconstruction environment containing the K232712 software changes.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-02 · FDA K232712: uMI Panorama

  4. Returned objects

    Source context, not route validation: High quality functional and anatomical images, with accurate registration and fusion of PET and CT images; uKinetics generates direct and indirect parametric images.

    Scope: Exact FDA submission. The exact device description and indications for use support the image, registration/fusion, and uKinetics output wording without adding the dossier's unsupported review claim.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K232712: uMI Panorama

  5. Viewer/worklist/report

    Unresolved route: High quality functional and anatomical images, with accurate registration and fusion of PET and CT images; uKinetics generates direct and indirect parametric images.

    Scope: Exact FDA submission. The exact device description and indications for use support the image, registration/fusion, and uKinetics output wording without adding the dossier's unsupported review claim.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K232712: uMI Panorama

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
On-premises uMI Panorama 28 or 35 PET/CT scanner with a 760 mm bore, integrated patient table, and system control and reconstruction environment containing the K232712 software changes.
  • Exact FDA submission
  • Checked 2026-09-02
Integration
The scanner control and reconstruction environment provides data and patient management, networking, display and post-processing, and DICOM-standard image exchange.
  • Exact FDA submission
  • Checked 2026-09-02

Confirm supported DICOM services, object types, PACS and RIS connectivity, worklist behavior, quantitative-image handling, and interface versions for the installed configuration.

Security
United Imaging Healthcare's cybersecurity page lists a secure development lifecycle and controls: firewall, encrypted connections, OS hardening, antivirus, patches, authentication, audit log, disk and transmission encryption. Company-level, not release-specific.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation; exact-release scope is not established.

Scanner configuration

Integrated PET and 160-slice CT system with 280 mm or 350 mm PET axial field of view, a 760 mm bore, and a maximum table load of 318 kg.

exact submission · checked 2026-09-02

Confirm ordered detector coverage, table accessories, room requirements, power, cooling, shielding, and service clearances.

Updated quantitative PET functions

K232712 adds deep learning to uExcel Focus or OncoFocus respiratory-motion correction and adds uKinetics for direct and indirect PET parametric imaging.

exact submission · checked 2026-09-02

Confirm licensed options, supported tracers and acquisition protocols, processing time, output objects, and local quantitative quality-control procedures.

DICOM and system workflow

Provides DICOM-standard image exchange plus patient and data management, networking, image display, post-processing, and filming functions within the scanner environment.

exact submission · checked 2026-09-02

Validate modality worklist, accession and patient reconciliation, PACS routing, quantitative-image preservation, and downstream viewer compatibility.

Current product-family context

United Imaging's current uMI Panorama family page describes 28 cm and 35 cm scalable PET axial fields of view, a 76 cm bore, 318 kg table capacity, 160 CT slices per rotation, and uExcel AI workflow features.

product family · checked 2026-09-02

Current family-page claims may span configurations or software releases; map them to the quoted and installed system before procurement or validation.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K232712
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
PET/SPECT/Nuclear Medicine
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

The exact indications for use state that the uMI Panorama combines the two imaging modalities PET and CT. Controlled directory display reconciled from exact FDA wording: PET and CT -> PET/SPECT/Nuclear Medicine.

Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2023-10-03
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
23Fields reviewed
10Source classes checked
8Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains 8 PubMed and 0 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 8 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. 1 FDA recall candidate was manually reviewed: 1 published and 0 rejected as a neighboring or otherwise inapplicable version. Native FDA recall identifiers produced 1 postmarket candidate record; 1 has been reviewed (1 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda device recall, vendor product page, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-10-27 - Exact FDA submission

    No public price or quote for the exact K232712 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "United Imaging uMI Panorama reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-10-27 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA K232712: uMI Panorama

    U.S. Food and Drug Administration - Published 2023-10-03 - Accessed 2026-09-19

    Scope: purpose, anatomy, modality, intendedUsers, input, output, limitations, evidenceSummary, clinicalUse

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. FDA recall Z-0225-2026: Shanghai United Imaging Healthcare Co., Ltd. Positron Emission Tomography and Computed Tomography System Model:uMI Panorama 35 MD, Rx Only

    U.S. Food and Drug Administration - Published 2025-10-21 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. uMI Panorama product-family page

    United Imaging Healthcare - Accessed 2026-09-02

    Scope: productFamily, implementationCapabilities, currentCommercialContext

  8. United Imaging Healthcare Cybersecurity

    United Imaging Healthcare - Accessed 2026-10-25

    Scope: security

Research history

  1. K232712 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K231572

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation in oncology, cardiology, neurology, inflammation, infection, and other disorders. The CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-07-26
FDA-cleared K223325

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-03-10
FDA-cleared K251528

syngo.via MI Workflows; Scenium; syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via MI Workflows, Scenium, and syngo MBF provide PET, SPECT, nuclear-medicine, CT, and MR viewing, manipulation, quantification, longitudinal comparison, and analysis for oncology, cardiology, neurology, organ function, and selected radiation-planning support.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2025-07-03
FDA-cleared K241585

uMI Panorama

Shanghai United Imaging Healthcare Co.,Ltd.

Authorized purpose: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation. K241585 adds reconstruction, respiratory-motion, CT-less attenuation-correction, quantitative-normalization, quality-control, and AI-expanded-field-of-view functions.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2024-08-30

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history